Edward A. Levine
Papers
1
Total Citations
3
H-Index
1
About
Edward A. Levine is a pioneering surgical oncologist whose career has been defined by advancing the treatment of peritoneal surface malignancies. His primary research focuses on cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC), a complex, life-extending procedure for cancers that spread within the abdominal cavity. Levine’s major contributions include refining surgical techniques and expanding the application of CRS/HIPEC, particularly for mucinous neoplasms of the appendix, ovarian cancer, and colorectal cancer. He has been instrumental in demonstrating the procedure’s viability and improving patient outcomes, with his work cited over 3,000 times. Notably, his recent exploration of robotic-assisted minimally invasive approaches—as seen in his 2023 paper on the robotic future of CRS/HIPEC—signals his commitment to reducing surgical morbidity while maintaining oncologic efficacy. Levine’s leadership in this niche field has established him as a key figure in surgical oncology, bridging aggressive cytoreduction with innovative technology to offer hope to patients with otherwise limited options.
Research Focus
Key Achievements
Top Papers
- 1